WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market ...Middle East

SUZHOU, China, June 18, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing Center in Suzhou has successfully passed a Good Manufacturing Practice (GMP) inspection by...

Hence then, the article about wuxi biologics suzhou biosafety testing center received fourth ema gmp certification enabling 19 commercial products for the european market was published today ( Thursday 18/06/2026 - 07:59 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market )

Also on site :

• Variety Announces Brand Entertainment for Fans  Event Spotlighting Leaders at Cannes Lions
• Sam’s Club is Selling a Giant Bag of Lucky Charms Marshmallows For Just $9–and There’s a Magical Surprise Inside
• G7 considering licensed arms production in Ukraine: Why now?